Fitness centre Medifit & Fix My Nutrition to merge

NEW DELHI: Bengaluru-based fitness centre Medifit Consultants is investing in and merging health and beverage company Fix My Nutrition into its own operations. Although the deal size was not disclosed, sources said the company is investing around Rs 60 crore.

The merger appears to be an attempt to follow a model similar to that of Mukesh Bansal and Ankit Nagori’s Curefit, which combines different aspects of health. Started in 2005 by MBBS graduate Shardul Sinha, Medifit operates in the corporate fitness space and has 238 fitness centres across Indian tech parks, including campuses of Infosys, Dell, and SAP Labs. It sets up fitness centres and provides the space with trainers.

Fix My Nutrition, started by airline pilot Nubin John, provides customized healthy meal plans in Bengaluru and Hyderabad. With the merger, the operations of Fix My Nutrition will come under Medifit’s brand while Medifit will start providing its corporate clients with meal plans.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

    Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

    ‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

    ‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case